MLB, players agree to expanded drug testing

35 Comments

Michael S. Schmidt of the New York Times reports that Major League Baseball and the MLBPA have agreed to expand the drug testing program. Specifically, they have agreed to start in-season blood testing for human growth hormone and to implement a new test designed to better police testosterone use.

Previously, HGH testing — which requires blood draws — had been limited to spring training. Some players had voiced reservations about giving blood, say, before a game, but the objections were obviously dispensed with.

The new testosterone test is more interesting, as there has been a growing chorus of voices saying that more and more players have turned to testosterone as their PED of choice in recent years. Melky Cabrera and Bartolo Colon were suspended for using testosterone last season. Ryan Braun tested positive for testosterone at the end of the 2011 season, but had his suspension overturned on appeal.

The league is expected to formally announce these changes later today.

Report: Nathan Eovaldi drawing interest from at least nine teams

Nathan Eovaldi
Getty Images
5 Comments

Former Red Sox right-hander Nathan Eovaldi is up for grabs this offseason, and Nick Cafardo of the Boston Globe says that as many as nine suitors are interested in bringing the righty aboard. While the Red Sox are eager to retain Eovaldi’s services after his lights-out performance during their recent postseason run, they’ll have to contend with the Brewers, Phillies, Braves, White Sox, Padres, Blue Jays, Giants, and Angels — all of whom are reportedly positioned to offer something for the starter this winter.

It wasn’t all smooth sailing for the 28-year-old in 2018, however. After losing his 2017 season to Tommy John surgery, he underwent an additional procedure to remove loose bodies from his right elbow in March and didn’t make his first appearance until the end of May. He was flipped for lefty reliever Jalen Beeks just prior to the trade deadline and finished his season with a combined 6-7 record in 21 starts, a 3.81 ERA, 1.6 BB/9, and 8.2 SO/9 through 111 innings.

Despite his numerous health issues over the last few years, Eovaldi raised his stock in October after becoming a major contributor during the Red Sox’ championship run. He contributed two quality starts in the ALDS and ALCS and returned in Games 1-3 of the World Series with three lights-out performances in relief — including a six-inning effort in the 18-inning marathon that was Game 3.

A frontrunner has yet to emerge for the righty this offseason, but Cafardo points out that the nine teams listed so far might just be the tip of the iceberg. Still, he won’t be the most sought-after starter on the market, as former Diamondbacks southpaw Patrick Corbin is expected to command an even bigger payday following his career-best 6.0-fWAR performance in 2018.